UK On Cusp Of Integrated Care And New Regulatory Fees But Innovation Adoption Pressures Remain
UK patients see benefits of AI but medtech industry must take heed of changes ushered in by new Health and Care Act
Executive Summary
New medtech regulatory policy, technology adoption challenges and NHS architecture changes under the new Health and Care Act will give system UK users much to ponder over this summer.
You may also be interested in...
NHS England Consults On New Payment System
NHS England is canvassing views on its plan to establish the NHS Payment System, to replace the current national tariff payment system, from April 2023.
Vibrant IVDs Innovation Climate At Risk From Poor UK Regulatory System Readiness
The spotlight is on IVDs in the post-COVID phase. Innovators in university spin-outs and the established industry have responded with new technologies, creating a vibrant scene. Regulators and reimbursors must not disrupt the momentum, say BIVDA’s regulatory affairs manager Ashleigh Batchen and chief executive Doris-Ann Williams.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.